Видео с ютуба Avelumab

Avelumab Immunotherapy for Bladder Cancer - Bladder Cancer Video Library

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

Real-world outcomes of first-line avelumab maintenance in bladder cancer

Avelumab in locally advanced or metastatic solid tumors

Long term outcomes in JAVELIN Bladder 100: avelumab in urothelial carcinoma

AVELIN Bladder 100: Avelumab maintenance indicated as a SOC for advanced urothelial carcinoma

Dr. Andrea Apolo on Avelumab in Metastatic Bladder Cancer

Durable responses to avelumab in patients with Merkel cell carcinoma

Avelumab plus axitinib shows good efficacy for OS and PFS in aRCC patients

Managing the common adverse events of avelumab in the clinic

Dr. Infante on Avelumab's Potential in Ovarian Cancer

AXAGIST: Phase II trial of avelumab with axitinib in pre-treated GIST

Dr. Choueiri on Avelumab Plus Axitinib in mRCC

Adjuvant avelumab versus control does not significantly improve DFS but does improve OS in high-...

Avelumab and pembrolizumab for the treatment of merkel cell carcinoma

Avelumab Plus Best Supportive Care Shows Efficacy in Urothelial Carcinoma

FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma Transcript

Dr. Apolo on Avelumab for Metastatic Urothelial Carcinoma

Avelumab for Treatment of Metastatic Merkel Cell Carcinoma

Dr. Kaufman on Avelumab in Merkel Cell Carcinoma